Claire O’Donovan: what I’ve learned
Claire O'Donovan, biocurator and Metabolomics team leader at EMBL-EBI shares lessons from her career and life.
PEOPLE & PERSPECTIVES2025
people-perspectivesperspectives
Welcome: Hanh Vu
Group Leader Hanh Vu studies ‘immortal’ flatworms that can grow and de-grow to understand better factors that determine organisms’ sizes.
LAB MATTERSPEOPLE & PERSPECTIVES2023
lab-matterspeople-perspectives
Promoting European innovation in the life sciences
One of EMBL’s core missions is the development and transfer of scientific know-how and technologies to academia, industry, and commercial entities to facilitate further research, innovations, and commercialisation for the benefit of society at large. Working across Europe, EMBL has partnerships…
CONNECTIONSLAB MATTERS2023
connectionslab-matters
ERC Proof-of-Concept grant provides way to realise commercial potential of ‘SpaceM’ technology
A new grant will provide a way for fundamental metabolomic research to realise its commercial potential and promise in aiding drug development and precision medicine.
LAB MATTERSSCIENCE & TECHNOLOGY2022
lab-mattersscience-technology
Teamed up to innovate
A new formal collaboration agreement enables will help smooth the transition from fundamental science to innovation.
CONNECTIONSLAB MATTERS2022
connectionslab-matters
When ‘good’ cells go ‘bad’
If researchers can identify specifically when good cells go bad, they can potentially understand disease better.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Charting a multi-omic universe
A research collaboration used machine learning to map tumour molecular make-up, potentially paving way to more customised cancer treatment.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Common medications accumulate in gut bacteria
A new collaborative study led by EMBL group leaders Kiran Patil, Nassos Typas, and Peer Bork has found that common medications accumulate in human gut bacteria. This process reduces drug effectiveness and affects the metabolism of common gut microbes, thereby altering the gut microbiome.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Joining forces to solve global challenges
EMBL and the Swedish Science for Life Laboratory sign agreement to advance science together.
CONNECTIONSLAB MATTERS2021
connectionslab-matters
Painting liver cells
A page from a biologist’s colouring book? EMBL’s new interior wall design? Not quite – a bunch of liver cells, grown in the lab so that scientists can learn about fatty liver disease, or steatosis.
SCIENCE & TECHNOLOGY2021
picture-of-the-weekscience-technology
Programming: language
How computer processing of human language is harnessed by EMBL scientists
SCIENCE & TECHNOLOGY2019
sciencescience-technology
PhenoMeNal: an online portal for metabolomics
Complex metabolomics analyses in the cloud
SCIENCE & TECHNOLOGY2018
sciencescience-technology
Mapping molecules on people, fields and ATMs
Molecule mapping method raises interest in forensics, agriculture and microbiome studies
SCIENCE & TECHNOLOGY2017
sciencescience-technology
Improving data analysis in imaging mass spec
Open source bioinformatics method for finding metabolites makes experiments comparable across labs
SCIENCE & TECHNOLOGY2016
sciencescience-technology
It’s the economy, stupid
Theodore Alexandrov is using mathematics to analyse the countless molecules produced by our cells.
SCIENCE & TECHNOLOGY2015
sciencescience-technology
Welcome: Theodore Alexandrov
A mathematician who got ‘sucked in’ to biological problems, meet new team leader Theodore Alexandrov.
PEOPLE & PERSPECTIVES2015
people-perspectivesscience
No results found